Haima Therapeutics, LLC

 

is a pre-clinical stage biotechnology company focused on developing bio-inspired

therapies for treatment of bleeding and other blood-related ailments.

 
 

SynthoPlatE

is a novel nanoparticle-based synthetic platelet technology that can stop bleeding quickly

by mimicking and amplifying your body's natural clotting mechanisms. LEARN MORE